Presima Securities ULC Has $17.36 Million Stock Holdings in Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Presima Securities ULC increased its holdings in Sabra Healthcare REIT, Inc. by 13.9%, reaching a stake worth $17.36 million, representing about 3.9% of its total portfolio.
• Multiple analysts have raised their price targets for Sabra Healthcare REIT, with a consensus average target price of $20.71, indicating a generally positive outlook on the stock.
• Sabra Healthcare REIT recently announced a quarterly dividend of $0.30 per share, translating to a dividend yield of 6.3%, although the company's dividend payout ratio stands at 157.89%.

Presima Securities ULC grew its holdings in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 13.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 993,688 shares of the real estate investment trust's stock after buying an additional 121,323 shares during the period. Sabra Healthcare REIT accounts for about 3.9% of Presima Securities ULC's portfolio, making the stock its 11th biggest holding. Presima Securities ULC owned approximately 0.42% of Sabra Healthcare REIT worth $17,360,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. UniSuper Management Pty Ltd raised its stake in Sabra Healthcare REIT by 3.2% in the 1st quarter. UniSuper Management Pty Ltd now owns 66,824 shares of the real estate investment trust's stock valued at $1,167,000 after acquiring an additional 2,100 shares during the period. Uniplan Investment Counsel Inc. acquired a new position in shares of Sabra Healthcare REIT in the first quarter valued at $3,294,000. Hancock Whitney Corp raised its position in shares of Sabra Healthcare REIT by 1.9% in the first quarter. Hancock Whitney Corp now owns 209,923 shares of the real estate investment trust's stock valued at $3,667,000 after purchasing an additional 3,888 shares during the period. Alliancebernstein L.P. lifted its stake in shares of Sabra Healthcare REIT by 5.7% during the 1st quarter. Alliancebernstein L.P. now owns 1,439,164 shares of the real estate investment trust's stock worth $25,142,000 after buying an additional 78,090 shares during the last quarter. Finally, AQR Capital Management LLC lifted its stake in shares of Sabra Healthcare REIT by 12.1% during the 1st quarter. AQR Capital Management LLC now owns 1,370,813 shares of the real estate investment trust's stock worth $23,948,000 after buying an additional 147,955 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock traded down $0.15 during mid-day trading on Wednesday, reaching $18.93. 3,020,694 shares of the company were exchanged, compared to its average volume of 2,356,063. The firm has a market cap of $4.54 billion, a PE ratio of 12.89, a PEG ratio of 1.52 and a beta of 0.88. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80. The company has a fifty day simple moving average of $18.66 and a 200-day simple moving average of $17.92. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last released its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm had revenue of $189.15 million during the quarter, compared to the consensus estimate of $185.64 million. During the same period in the prior year, the company posted $0.36 EPS. The company's revenue was up 7.4% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.3%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is currently 157.89%.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Wells Fargo & Company increased their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an "overweight" rating in a report on Wednesday, August 27th. Truist Financial lifted their price target on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a report on Tuesday, September 2nd. BMO Capital Markets boosted their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a "market perform" rating in a research note on Monday, August 25th. JMP Securities increased their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 6th. Finally, Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a "sector perform" rating in a research report on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $20.71.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.